Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;157(3):435-443.
doi: 10.1007/s11060-022-03987-9. Epub 2022 Mar 25.

Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions

Evan H Einstein  1 , Nicholas B Dadario  2 , Hamza Khilji  3 , Justin W Silverstein  4   5 , Michael E Sughrue  6 , Randy S D'Amico  3
Affiliations
Review

Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions

Evan H Einstein et al. J Neurooncol. 2022 May.

Erratum in

Abstract

Introduction: Transcranial magnetic stimulation (TMS) is a neuromodulation technology capable of targeted stimulation and inhibition of cortical areas. Repetitive TMS (rTMS) has demonstrated efficacy in the treatment of several neuropsychiatric disorders, and novel uses of rTMS for neurorehabilitation in patients with acute and chronic neurologic deficits are being investigated. However, studies to date have primarily focused on neurorehabilitation in stroke patients, with little data supporting its use for neurorehabilitation in brain tumor patients.

Methods: We performed a review of the current available literature regarding uses of rTMS for neurorehabilitation in post-operative neuro-oncologic patients.

Results: Data have demonstrated that rTMS is safe in the post-operative neuro-oncologic patient population, with minimal adverse effects and no documented seizures. The current evidence also demonstrates potential effectiveness in terms of neurorehabilitation of motor and language deficits.

Conclusions: Although data are overall limited, both safety and effectiveness have been demonstrated for the use of rTMS for neurorehabilitation in the neuro-oncologic population. More randomized controlled trials and specific comparisons of contralateral versus ipsilateral rTMS protocols should be explored. Further work may also focus on individualized, patient-specific TMS treatment protocols for optimal functional recovery.

Keywords: Brain tumors; Neuromodulation; Neurorehabilitation; Post-operative; Recovery; TMS.

PubMed Disclaimer

References

    1. Merton PA, Morton HB (1980) Stimulation of the cerebral cortex in the intact human subject. Nature 285(5762):227. https://doi.org/10.1038/285227a0 - DOI - PubMed
    1. Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH et al (2014) Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 125(11):2150–2206. https://doi.org/10.1016/j.clinph.2014.05.021 - DOI - PubMed
    1. Klomjai W, Katz R, Lackmy-Vallee A (2015) Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Ann Phys Rehabil Med 58(4):208–213. https://doi.org/10.1016/j.rehab.2015.05.005 - DOI - PubMed
    1. Galletta EE, Rao PR, Barrett AM (2011) Transcranial magnetic stimulation (TMS): potential progress for language improvement in aphasia. Top Stroke Rehabil 18(2):87–91. https://doi.org/10.1310/tsr1802-87 - DOI - PubMed - PMC
    1. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A (2000) Modulation of corticospinal excitability by repetitive transcranial magnetic stimulation. Clin Neurophysiol 111(5):800–805. https://doi.org/10.1016/s1388-2457(99)00323-5 - DOI - PubMed

MeSH terms

LinkOut - more resources